[1]刘 震,潘 涛,张 涛,等.膝下靶动脉重建新理念“Angiographosome”临床应用效果 [J].介入放射学杂志,2021,30(10):994-997.
 LIU Zhen,PAN Tao,ZHANG Tao,et al.The clinical application of the new concept of “angiographosome” in revascularization of target artery below knee joint[J].journal interventional radiology,2021,30(10):994-997.
点击复制

膝下靶动脉重建新理念“Angiographosome”临床应用效果

()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年10
页码:
994-997
栏目:
血管介入
出版日期:
2021-10-25

文章信息/Info

Title:
The clinical application of the new concept of “angiographosome” in revascularization of target artery below knee joint
作者:
刘 震 潘 涛 张 涛 李 城 纪东华
Author(s):
LIU Zhen PAN Tao ZHANG Tao LI Cheng JI Donghua.
Department of Interventional Therapy, Affiliated First Hospital of Dalian Medical University, Dalian, Liaoning Province 116011, China
关键词:
【关键词】 Angiographosome 血管重建 创面血管染色
文献标志码:
A
摘要:
【摘要】 目的 评价“Angiographosome”理念指导下靶动脉开通术治疗Rutherford 5、6级缺血的临床效果。方法 回顾性分析2018年6月至2019年6月单中心采用Angiographosome理念完成膝下靶血管重建术治疗的20例下肢缺血性溃疡患者临床资料。其中Rutherford 5级缺血16例,6级缺血4例。术后1、3、6个月随访观察创面愈合情况及截肢、死亡事件。 结果 20例膝下靶血管开通术均获成功,无手术技术相关并发症发生。术后1、3、6个月创面愈合率分别为30%(6/20)、70%(14/20)、80%(16/20),其中Rutherford 5级缺血患者分别为37.5%(6/16)、87.5%(14/16)、100%(16/16);术后6个月Rutherford 6级缺血患者创面缩小明显,但未完全愈合。随访期所有患者无大截肢事件和死亡事件发生。 结论 Angiographosome理念指导下膝下靶血管开通术安全有效,尤其是对Rutherford 5级缺血患者,可取得良好的创面愈合率和保肢率。

参考文献/References:

[1] Do CS, Herman KC, Gallo V, et al. Angiographosome- directed revascularization[J]. Endovascular Today, 2018, 17: 52- 58.
[2] 纪东华.膝下动脉腔内治疗新概念[J].中华血管外科杂志,2019, 4:135- 137.
[3] Attinger CE, Evans KK, Bulan E, et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization[J]. Plast Reconstr Surg, 2006, 117: 261S- 293S.
[4] Iida O, Soga Y, Hirano K, et al. Long- term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below- the- knee lesions[J]. J Vasc Surg, 2012, 55: 363- 370.
[5] Iida O, Nanto S, Uematsu M, et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia[J]. Catheter Cardiovasc Interv, 2010, 75: 830- 836.
[6] Azuma N, Uchida H, Kokubo T, et al. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?[J]. Eur J Vasc Endovasc Surg, 2012, 43: 322- 328.
[7] Neville RF, Attinger CE, Bulan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter?[J]. Ann Vasc Surg, 2009, 23: 367- 373.
[8] Alexandrescu V, Hubermont G. The challenging topic of diabetic foot revascularization: does the angiosome- guided angioplasty may improve outcome[J]. J Cardiovasc Surg(Torino), 2012, 53: 3- 12.
[9] Alexandrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: below- the- knee angiosome- oriented angioplasty[J]. J Endovasc Ther, 2011, 18: 376- 387.
[10] Varela C, Acin F, de Haro J, et al. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model[J]. Vasc Endovascular Surg, 2010, 44: 654- 660.
[11] 纪东华,张 涛,李 城,等. Angiosome指导下膝下动脉成形术治疗合并糖尿病的Fontaine Ⅳ级下肢动脉缺血[J]. 中国微创外科杂志, 2013, 13:789- 792.
[12] Alexandrescu V, Soderstrom M, Venermo M. Angiosome theory: fact or fiction?[J]. Scand J Surg, 2012, 101: 125- 131.
[13] Utsunomiya M, Nakamura M, Nakanishi M, et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia[J]. J Vasc Surg, 2012, 55: 113- 121.
[14] Utsunomiya M, Takahara M, Iida O, et al. Wound blush obtainment is the most important angiographic endpoint for wound healing[J]. JACC Cardiovasc Interv, 2017, 10: 188- 194.

备注/Memo

备注/Memo:
(收稿日期:2020- 06- 03)
(本文编辑:边 佶)
更新日期/Last Update: 2021-10-13